Objectives Limited awareness of cancer symptoms results in patient delay in seeking help and contributes to delay in diagnosis. Few UK studies have investigated the potential for community pharmacists to facilitate earlier detection of cancer. This study aimed to investigate what actions patients take to manage their early cancer symptoms, to identify the extent of current community pharmacy involvement and to consider the potential role for community pharmacists to facilitate appropriate management and appraisal of potential early cancer symptoms. Methods Patients diagnosed with lung, colorectal or gastro-oesophageal cancer in the preceding 12 months were identified during clinic visits by consultants. Semi-structured interviews were conducted, audio-recorded, transcribed and thematically analysed, using the Framework Approach. Key findings Twenty-five consenting patients were interviewed: two-thirds were male and more than half had lung cancer. Although all had experienced potential cancer symptoms prior to diagnosis, most underestimated seriousness and misattributed causation. Symptoms were managed by lifestyle changes and self-selecting medicines from local shops, supermarkets and pharmacies but without engaging with the pharmacist. Conclusions For symptom management, participants self-selected medicines from community pharmacies, but pharmacy staff were rarely involved. Involving community pharmacists or their staff at the point of sale of these medicines might have facilitated earlier cancer diagnosis. Further research is needed to quantify how many patients with symptoms suggestive of cancer present in community pharmacies to understand if a pharmacist's role in facilitating symptom management and appraisal of potential cancer symptoms would be acceptable and effective, before developing any interventions.
Introduction
Earlier diagnosis of cancer improves performance status [1] and survival rates. [2] Patients in the United Kingdom (UK) are diagnosed with more advanced disease than those in other European countries which may partly explain poorer UK survival. [3] Delays in diagnosis occur at almost every stage of the cancer journey, but the biggest delay is between patients first noticing symptoms and consulting a GP. [4] Evidence shows that patients often experience symptoms for months before a lung cancer diagnosis but do not seek medical attention. [5] This delay is considered long enough to have an effect on treatment outcomes. [6] The National Awareness and Early Diagnosis Initiative (NAEDI) aims to reduce cancer mortality and improve cancer survival rates in the UK by promoting early detection. [7] People are encouraged to seek early professional advice for 'suspicious' symptoms that could be attributed to cancer. [7] However, public awareness of these, and risk factors associated with cancer, is low. [8] [9] [10] [11] [12] Some studies have proposed that more patient support in primary care, education about symptoms and research into patients' self-management of symptoms could facilitate earlier presentation, prompt referral and earlier diagnosis, potentially improving cancer outcomes. [5, 6] Most cancers produce early symptoms which are often mild, mimic minor illness and are self-treated using nonprescribed remedies. [13] Lung and colorectal cancers, two of the three most common cancers in Scotland, account for 27% and 18% of all cancer deaths, respectively. [14] These cancers have early symptoms (cough and changes in bowel habits/rectal pain respectively) which could be associated with less serious conditions, and for which patients often seek advice and treatment from community pharmacy.
Approximately 90% of the UK population visits a community pharmacy annually, [15] and patients value the selfcare counselling they receive from pharmacists. [16, 17] However, there is limited UK research examining the contribution of community pharmacists to the early detection of cancer.
In November 2010, The Royal Pharmaceutical Society of Great Britain (RPSGB) and the Roy Castle Lung Cancer Foundation (RCLCF) conducted an audit of the number of people with symptoms suggestive of lung cancer identified by community pharmacy staff. [18] The following year the audit was repeated targeting colorectal cancer. [19] These audits demonstrated that people, with signs and symptoms suggestive of lung or colorectal cancer, were presenting to community pharmacies and that pharmacists were able to advise these patients to seek medical attention, based on the type and number of presenting symptoms. However, referred patients were not followed up to establish if they attended a medical appointment and/or were subsequently diagnosed with cancer. Earlier research in America, investigating pharmacists' ability to identify cancer signs and symptoms, found that the majority of pharmacists were confident in their ability to identify symptoms of skin, breast and colorectal cancer but were less confident regarding other cancers. The participants rated further education on cancer symptoms as important. The researchers concluded that pharmacists could have an important role in early detection and prevention of cancer, but further education and evaluation of the impact of this on patient referrals and subsequent cancer diagnosis were necessary. [20] In summary, current evidence suggests there is a need to raise general public awareness of cancer symptoms, to expedite earlier GP consultations amongst those with such symptoms. This paper reports on the qualitative phase of a larger programme of work and focuses on three types of cancer: lung, gastro-oesophageal and colorectal, since their early symptoms are often self-managed through community pharmacy. The aim was to investigate what actions patients take to manage their early cancer symptoms, to identify the extent of current community pharmacy involvement and to consider the potential role for community pharmacists to facilitate appropriate management and appraisal of potential early cancer symptoms.
Materials and methods

Study design, setting and participants
A single qualitative, interview-based study was conducted with patients recruited from cancer outpatient clinics at Aberdeen Royal Infirmary, between January and August 2012. Participants were over 17 years of age, had received a diagnosis of gastro-oesophageal (GO), lung or colorectal cancer in the previous 12 months, and were considered, by their clinician, able to participate in the study and provide informed consent. The target recruitment was estimated at 30 patients: 15 from each of the lung, and gastro-intestinal oncology clinics however, when no new emerging themes were identified after two consecutive interviews (data saturation) no further interviews were conducted.
Participant identification and recruitment
Consecutive eligible patients were identified by the responsible clinician during outpatient clinics over an 8-month period and were given a study information pack. With their permission, they were referred to FN (a female pharmacist researcher, undertaking a PhD and with five years research experience) who was present in the clinic and was previously unknown to them. FN described the study and recorded the contact details of patients interested in participating. FN contacted patients one week later to obtain their verbal consent to participate and arrange a time for their one-to-one interview. Those declining consent were not contacted again.
Written consent was obtained immediately prior to conducting the face-to-face, audio-recorded, interviews (30-60 min long), which were conducted at a mutually convenient site (home or university) by FN. A prepiloted, semi-structured, topic guide (see Appendix S1), informed by the literature, [4, 6, 8, 10, 12, [21] [22] [23] [24] [25] was used to establish the participant's awareness, experience and assessment of their cancer symptoms, and obtain basic demographic information. The topic guide explored participants' actions to manage their symptoms, including any community pharmacy involvement.
A Landmark Calendar Instrument [26] [27] [28] was used to aid participants' recall of symptoms. Symptom lists for the three cancers were developed from published sources [29] [30] [31] [32] [33] [34] [35] [36] and were used at interview as prompts to identify symptoms participants may have experienced but had not attributed to their cancer. Field-notes were made following the interviews.
Data analysis and reporting
Interview recordings were transcribed verbatim by FN, and a 10% (n = 3) random sample was independently checked for transcription accuracy by TP. Transcripts were anonymised; participants were identified only by a unique ID number, their sex, age and cancer type.
Data were stored and managed using Nvivo 9. [37] Content analysis was conducted using the Framework Approach. [38] A coding framework was developed by FN and independently validated by all members of the research team. The framework was iteratively revised as new themes emerged. All transcripts were coded by one person (FN), and a 10% (n = 3) random sample of coded transcripts was independently double coded by TP to check coding accuracy and consistency.
A thematic framework (Table 1) was developed based on emergent key themes which were then synthesised into broader concepts. Recruitment, interviewing, transcription and analysis were carried out simultaneously.
Direct quotes from transcripts are presented in Table 2 and assigned to the appropriate participant using the following identification format: [Male/Female, Age band, Cancer Type].
Approval to undertake the project was granted by the North of Scotland Research Ethics Committee (1) 11/NS/ 0028 on 27 October 2011.
Results
Participant characteristics
Of the 35 patients diagnosed with cancer, contacted by the researcher, eight were too unwell or declined to participate, 25 were interviewed before data saturation was achieved and recruitment was stopped and the remaining two were thanked for their interest but were not interviewed. Participant characteristics are summarised in Table 3 . There was no suggestion of any influence of age or gender across the different cancer types. The Landmark Calendar revealed the period of longest delay was the time between the participants' first experiencing symptoms and consulting their doctor (patient delay) [21] and varied from zero to 10 months.
Findings are reported under four main concepts: symptoms experience and appraisal; strategies for self-management of symptoms; triggers and barriers to help-seeking behaviour and sources of help.
Symptoms experience and appraisal
Prior to prompting with a symptoms list, participants identified specific 'first' symptoms: breathlessness, lethargy and cough (lung cancer participants); rectal pain (colorectal cancer participants); and pain or difficulty swallowing (GO cancer participants). However, participants also commonly experienced nonspecific symptoms they struggled to define (Quote 1). Lack of energy and tiredness were consistently mentioned, as having most impact on them and their daily activities (Quote 2). A minority of patients were unaware of experiencing any symptoms and cancer was diagnosed incidentally as a result of an unrelated hospital admission or atypical or sudden onset of acute symptoms, for example, one participant reported coughing up blood, another reported leg pain as their first symptom (Quote 3). Another recalled no symptoms at all, but admission to hospital, after falling in the street, resulted in opportunistic detection of lung cancer. Symptoms impacted on family lives and ability to engage in family celebrations. While family members expressed concern about the participants' symptoms, particularly weight loss, participants frequently reported not being emotionally affected by their symptoms until they worsened and persisted (Quote 4).
There was a widespread lack of awareness of risk factors and 'red-flag symptoms' [39] [40] [41] associated with cancer. Unless participants experienced progressively worsening pain or unexplained bleeding, they did not assess their initial symptoms as serious, dismissing them or associating them with their lifestyle (smoking or eating habits), minor illnesses (piles, cold or indigestion), injuries (pulled muscle, cracked ribs), their age or other pre-existing medical condition (MS, heart conditions) (Quote 5). Some participants did not attribute their symptoms to anything until they were diagnosed and the majority never thought they had cancer (Quote 6).
All participants reported experiencing at least one symptom, when prompted with the relevant symptom list, which they had not attributed to their cancer prior to the interview. Symptoms most frequently reported were weight loss and tiredness, with breathlessness, cough, loss of appetite and hoarseness also commonly reported. 
Strategies for self-management of symptoms
Participants took different actions to manage their initial symptoms: few consulted their doctor, but more than half self-managed their symptoms using over-thecounter medicines purchased from a pharmacy or supermarket, or which they had at home, for example cough mixtures, lozenges, haemorrhoid treatments, indigestion/reflux remedies and analgesics. Participants who attended a community pharmacy tended to self-select medicines rather than ask for advice: only three participants sought symptom advice from a pharmacist. Participants did not consistently purchase medicines from the same place, but when they did, frequent purchases of the same medicine were unchallenged (Quote 7). Some participants implemented lifestyle changes to manage their symptoms, for example changes to their diet, drinking water to facilitate swallowing, resting or sleeping and a few tried alternative therapies (Quote 8).
However, some participants took no medicines or action to manage their symptoms. They thought their symptoms would go away or tried to forget about them and continued on with their daily routine.
Triggers and barriers to help-seeking behaviour
The main triggers for seeking professional help were worsening or unresolved symptoms, new additional symptoms, or an increasing awareness of their symptoms impacting on their normal activities. Participants frequently reported being encouraged to attend their GP by friends/family, but did not always act on this. Occasionally, previous experience of illness with similar symptoms triggered helpseeking behaviour; however, their attribution of symptoms to their previous illness was incorrect (Quote 9). The main barriers to accessing help were participant related and linked to symptom awareness and appraisal.
Sources of help
Most discussed their symptoms with their immediate family and/or close friends.
Some participants stated they would go to their GP if they were ill and needed help from a health care professional, but they frequently reported only visiting the doctor when absolutely necessary, and expressed concern about wasting health professionals' time. Others cited lack of faith in their GP practice, attitude of the GP and reception staff, a dislike of hospitals, a dislike of taking medicines, a fear of catching other 'bugs' while in hospital, embarrassment about the symptoms or the area of the body affected, and living in a remote area as barriers to accessing help from their GP (Quote 10).
A few participants chose to visit a pharmacy before seeking help from their GP. Although the majority of these did not speak to counter staff or the pharmacist, the three who asked for a pharmacist's advice were appropriately referred and were happy with the advice and treatment given (Quote 11). Participants were unaware of the advisory role of pharmacists, with most considering the pharmacist's role as one of medicines supply. They therefore had not considered visiting a pharmacist for help (Quote 12). However, some expressed the view that pharmacists had a bigger role in healthcare delivery (Quote 13).
The main barrier to accessing pharmacy support was a lack of awareness that pharmacists were suitably skilled to respond appropriately to their symptoms (Quote 14). Others included perceived lack of privacy, the openness of the premises, the pharmacy being busy, the age and sex of the counter staff and a reluctance to be questioned about their symptoms.
Discussion
This exploratory interview study found that people with early symptoms of cancer purchase OTC medicines, sometimes from a pharmacy, rarely seeking advice from a pharmacist and with frequent purchases of the same medicine remaining unchallenged. Although few interviewees sought a pharmacist's advice about their symptoms, those that did were appropriately referred, however, there was a general lack of awareness regarding the pharmacist's skills and knowledge or role beyond that of medicines supply; in addition, barriers to accessing pharmacy services were identified. This study also found that participants demonstrated a lack of knowledge regarding cancer related and 'red-flag' symptoms resulting in a failure to both recognise and appraise early cancer symptoms. This lead to participants employing a variety of inappropriate strategies and delays in seeking advice from healthcare professionals and diagnosis. Other strategies for symptom management included discussing symptoms with friends/family and lifestyle changes. New or worsening symptoms, lay advice, or symptoms that interfered with their daily activities, prompted patients to seek help primarily from their GP.
This qualitative study highlights critical points in the patient journey when community pharmacists could have intervened and provides further insights into some reasons for patient delay.
Strengths and limitations of study
Strengths
To our knowledge, this is the first published study to investigate how people with cancer interacted with a community pharmacist in the lead-up to their cancer diagnosis in order to inform a potential role for community pharmacists in earlier diagnosis.
The research methods used were robust: participants were recruited by the consultants from clinics to reduce the risk of bias towards regular community pharmacy users; the interview schedule was informed by current literature; the same person coded all interview transcripts, eliminating the potential for inter-coder variation; participants were unaware the researcher was a pharmacist reducing the risk of bias in interview responses; a recognised robust approach (the Framework Approach) was used to analyse, interpret and synthesise the data; the transcription, coding and data entry were all independently validated and a landmark calendar facilitated participant recall.
Limitations
The sample was two-thirds male and one-third female. The cancers under investigation are more prevalent in males than females, which may explain the apparent overrepresentation of males in the sample. Since males are less likely to visit community pharmacies, [42] this may have impacted on the extent to which our participants accessed pharmacy services. The population in this study was older so their symptom management behaviour may not reflect that of the overall population. It is not known how many patients were approached to participate or how many declined to speak to the researcher, because Ethics denied the request for the consultants to complete a tally of clinic patients with this detail.
Implication for community pharmacy
Previously pharmacies were the most common source for OTC medicines, [43] however, participants in our study frequently made purchases from supermarkets and/or repeat purchases from more than one pharmacy, limiting opportunities for pharmacists to interact with patients or for patterns of purchasing to be noted.
Medicine deregulation was introduced to increase safe and convenient public access to medicines and reduce GP workload for managing minor ailments. However, further deregulation means medicines are more widely available. Accessing medicines from non-regulated outlets diminishes the status of medicines to that of commodity items, reinforcing the perception that symptoms treated by these medicines are therefore minor. In this study, selfmedicating with self-selected OTC medicines was the most popular strategy for symptom management and represents a missed opportunity for interaction with a healthcare professional. The continued purchase and use of OTC medicines from a variety of sources removed the opportunity for pharmacists to intervene, provide appropriate advice, facilitate accurate symptom appraisal and reduce inappropriate medicines use, which could potentially have led to earlier referral and diagnosis.
Although some participants visited community pharmacies, they rarely sought pharmacists' advice about their symptoms and multiple purchases of the same medicines over a short period of time were unchallenged. This study showed participants lacked awareness of the pharmacist's role, beyond supplying medicines, that is, the provision of professional advice and information regarding symptoms without the requirement for an appointment. Pharmacists and their staff should be more pro-active in engaging patients in discussion about their symptoms since in this study, those who asked the pharmacist for help were happy with the support they received and acted on their advice. Community pharmacists have been shown to appropriately advise patients presenting at a community pharmacy with potential cancer symptoms, to seek medical attention. [18, 19] Raising public awareness of the knowledge and advice available from pharmacists, their ability to recognise and appraise symptoms, and make appropriate referrals, could encourage increased pharmacist consultations.
To increase patient consultations with community pharmacists about potential cancer symptoms, identified barriers such as lack of privacy, the pharmacy being busy, the age and sex of the counter staff and a reluctance to be questioned about their symptoms should be minimised. This could be done by encouraging use of consultation rooms, upskilling dispensing staff to allow pharmacists time to address the patients' needs, improving the communication, questioning and empathic skills of the pharmacy staff and ensuring they are knowledgeable about symptom management and when to refer to the pharmacist. The findings of this study therefore have implications for the development of any potential community pharmacist intervention to improve detection of early cancer symptoms.
Other findings in the context of the literature
Our findings, show lack of awareness of symptoms, risk factors, and 'red-flag symptoms' and failure to assess symptoms as those of an illness, contribute to delay. These findings are reflected in the substantial body of evidence established in the published literature about symptom experience and assessment. [1, [8] [9] [10] [11] [12] 44] The evidence strongly suggests that these are key factors in cancer patients' delayed presentation and that identification of the existence of an illness is a necessary condition for seeking help. More accurate symptom appraisal may therefore expedite GP consultation.
Consistent with published literature, [45] our study identified the period of 'patient delay' as a potential point in the patient journey to implement effective interventions to promote appropriate help-seeking behaviour. Similarly, the help-seeking triggers identified in this study have previously been documented. [44, 46, 47] 
Areas for further research
This study has identified some interaction with community pharmacists but has also identified a number of missed opportunities where current community pharmacy services could be developed to enable pharmacists and their staff to take a role in the earlier detection of cancer.
Developmental research is now required to devise interventions which address the missed opportunities for community pharmacists to facilitate earlier diagnosis of cancer. This research should follow the MRC Framework for developing complex interventions prior to proposing any community pharmacy-based intervention.
Conclusion
Despite recent awareness campaigns people still fail to recognise their cancer symptoms, they self-medicate and delay seeking help. In this study, many of the participants attended community pharmacies to purchase medicines but did not interact with pharmacist about their symptoms. Those who did interact with the pharmacist were referred and were subsequently diagnosed with cancer confirming appropriateness. Thus, there is potential for more community pharmacist involvement in both advising on symptoms and referring on. However, for this to happen patients need to make more use of pharmacists' skills. Further research is needed prior to developing any intervention.
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